Suggestions
Tatyana Kanzaveli
Founder and CEO of Open Health Network; Forbes Next1000; strategic advisor: AI, Generative AI, innovations; TEDx speaker, chess master
Tatyana Kanzaveli is a renowned figure in the healthcare and technology industries, known for her innovative approach and impactful contributions.
With a rich background as a seasoned entrepreneur, thinker, leader, mentor, advisor, and investor, Tatyana has held senior executive roles in both large enterprises and startups, gaining vast experiences in both B2B and B2C markets.
Her expertise has been recognized on a global scale, having been featured on prestigious platforms such as the White House Science and Technology Blog and speaking at notable events like the United Nations and various international conferences.
Tatyana is a prominent voice in the realm of healthcare technology, with key speaking engagements focusing on AI, blockchain, big data analytics, and innovations in healthcare across renowned platforms such as Harvard, HIMSS NorCal Innovations Conference, and the World Health Congress.
In addition to her professional endeavors, Tatyana holds a Master's degree in Computer Sciences from the Azerbaijan State Oil Academy and has been actively involved in various organizations including WomenInGenAI, Chess Queen’s Club, Branson Centre of Entrepreneurship - Caribbean, and 500 Startups.
She has also served in leadership positions such as CEO and Founder at Open Health Network, CEO at TEDxBayArea, and Resident Mentor at 500 Startups, among others.
Tatyana Kanzaveli's extensive career includes roles in sales, marketing, business development, consultancy, and executive positions at notable companies like PricewaterhouseCoopers, SupportSoft, and Kaidara Software, showcasing her versatile skill set and broad industry knowledge.
Highlights
𝐓𝐡𝐞 𝐦𝐨𝐬𝐭 𝐯𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐔𝐈 𝐢𝐧 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐢𝐬 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧—𝐰𝐡𝐞𝐧 𝐢𝐭’𝐬 𝐝𝐨𝐧𝐞 𝐰𝐢𝐭𝐡 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐫𝐢𝐠𝐨𝐫.
We just published the randomized 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥 𝐩𝐫𝐨𝐭𝐨𝐜𝐨𝐥 𝐟𝐨𝐫 𝐓𝐀𝐌𝐈, 𝐚 𝐆𝐞𝐧𝐀𝐈-𝐚𝐬𝐬𝐢𝐬𝐭𝐞𝐝 𝐌𝐨𝐭𝐢𝐯𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰𝐢𝐧𝐠 coach for 𝐬𝐦𝐨𝐤𝐢𝐧𝐠 𝐜𝐞𝐬𝐬𝐚𝐭𝐢𝐨𝐧 (𝐶𝑜𝑛𝑡𝑒𝑚𝑝𝑜𝑟𝑎𝑟𝑦 𝐶𝑙𝑖𝑛𝑖𝑐𝑎𝑙 𝑇𝑟𝑖𝑎𝑙𝑠).
Co-authored with UCSF Health ; technology by Open Health Network .
𝐖𝐡𝐲 𝐭𝐡𝐢𝐬 𝐦𝐚𝐭𝐭𝐞𝐫𝐬 (𝐞𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞 𝐥𝐞𝐧𝐬):
•𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐠𝐫𝐚𝐝𝐞, 𝐧𝐨𝐭 𝐝𝐞𝐦𝐨-𝐠𝐫𝐚𝐝𝐞. MI fidelity (real OARS, change vs. sustain talk, stage-matched pathways), re-engagement by design, and human handoffs when needed.
•𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐟𝐢𝐭. Built to live inside care-management workflows—EHR-friendly, auditable, and ready for navigator queues.
•𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐫𝐞𝐥𝐞𝐯𝐚𝐧𝐜𝐞. Starts with cessation (hard outcomes); extendable by evidence-first pilots to adherence, addictions, BH follow-ups, and chronic care—where plans feel avoidable cost and Stars pressure.
𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐩𝐞𝐞𝐫-𝐫𝐞𝐯𝐢𝐞𝐰𝐞𝐝 𝐩𝐫𝐨𝐭𝐨𝐜𝐨𝐥 (𝐟𝐫𝐞𝐞 𝐟𝐨𝐫 𝟓𝟎 𝐝𝐚𝐲𝐬) - comment “Paper” to get a link.
𝑺𝒄𝒐𝒑𝒆 𝒕𝒐𝒅𝒂𝒚: 𝒔𝒎𝒐𝒌𝒊𝒏𝒈 𝒄𝒆𝒔𝒔𝒂𝒕𝒊𝒐𝒏. 𝑹𝒐𝒂𝒅𝒎𝒂𝒑: 𝒂𝒅𝒂𝒑𝒕 𝒕𝒉𝒆 𝒔𝒂𝒎𝒆 𝑴𝑰 𝒆𝒏𝒈𝒊𝒏𝒆 𝒕𝒐 𝒂𝒅𝒉𝒆𝒓𝒆𝒏𝒄𝒆, 𝒂𝒅𝒅𝒊𝒄𝒕𝒊𝒐𝒏𝒔, 𝒂𝒏𝒅 𝒃𝒓𝒐𝒂𝒅𝒆𝒓 𝒃𝒆𝒉𝒂𝒗𝒊𝒐𝒓𝒂𝒍 𝒉𝒆𝒂𝒍𝒕𝒉 𝒕𝒉𝒓𝒐𝒖𝒈𝒉 𝒎𝒆𝒂𝒔𝒖𝒓𝒆𝒅, 𝒐𝒖𝒕𝒄𝒐𝒎𝒆𝒔-𝒅𝒓𝒊𝒗𝒆𝒏 𝒑𝒊𝒍𝒐𝒕𝒔.
Capabilities (what we actually build and ship): •MI-consistent patient/member coaches; clinician copilots; care-management tools •Data & model pipelines (RAG, eval, guardrails), privacy/security, audit trails •Integrations: FHIR/EHR, claims/PBM, devices/wearables; multilingual UX on the roadmap
𝐎𝐮𝐫 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐭𝐞𝐚𝐦 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐢𝐥𝐢𝐭𝐲:
limited 2025 build slots for health systems, payers, and life sciences teams seeking production-grade AI/GenAI offerings !

